XML 87 R70.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Paragon Agreement (Details) - USD ($) $ in Millions |  | 1 Months Ended | 12 Months Ended
--- | --- | --- | ---
Jun. 22, 2023 | May 31, 2023 | Dec. 31, 2023
Paragon Therapeutics Inc |  |  |
Related Party Transaction [Line Items] |  |  |
Milestone payments |  |  | $ 39.5
Parapyre Option Obligation |  |  |
Related Party Transaction [Line Items] |  |  |
Percentage of annual equity grant of options | 1.00% | 1.00% |
Paragon Agreement |  |  |
Related Party Transaction [Line Items] |  |  |
Related party expenses incurred prior to asset acquisition | $ 19.0 |  |
Related party expenses unpaid prior to asset acquisition | 19.0 |  |
Stock Compensation And Research And Development Expense |  |  |
Related Party Transaction [Line Items] |  |  |
Related party transaction amount |  |  | $ 48.5
Related Party | Paragon Agreement |  |  |
Related Party Transaction [Line Items] |  |  |
Research initiation fees | 3.0 | $ 3.0 |
Related party expenses incurred prior to asset acquisition | 19.0 |  |
Reimbursable research costs | 16.0 |  |
Related party expenses unpaid prior to asset acquisition | 19.0 |  |
Nonrefundable research initiation fee for one program paid in cash | $ 0.8 |  |

X
- Definition License Agreement, Milestone Payments + References No definition available. + Details
Name: | syre_LicenseAgreementMilestonePayments
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Nonrefundable research initiation fee for one program paid in cash. + References No definition available. + Details
Name: | syre_NonrefundableResearchInitiationFeeForOneProgramPaidInCash
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Percentage of annual equity grant of options to purchase outstanding shares of common stock. + References No definition available. + Details
Name: | syre_PercentageOfAnnualEquityGrantOfOptionsToPurchaseOutstandingSharesOfCommonStock
Namespace Prefix: | syre_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Reimbursable research costs. + References No definition available. + Details
Name: | syre_ReimbursableResearchCosts
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Related party expenses incurred prior to asset acquisition. + References No definition available. + Details
Name: | syre_RelatedPartyExpensesIncurredPriorToAssetAcquisition
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Related party expenses unpaid prior to asset acquisition. + References No definition available. + Details
Name: | syre_RelatedPartyExpensesUnpaidPriorToAssetAcquisition
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Research initiation fees. + References No definition available. + Details
Name: | syre_ResearchInitiationFees
Namespace Prefix: | syre_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of transactions with related party during the financial reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-3 + Details
Name: | us-gaap_RelatedPartyTransactionAmountsOfTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(c)(2)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(c)(2)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(g)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1 + Details
Name: | us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=syre_ParagonTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=syre_ParapyreOptionObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=syre_ParagonAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=syre_StockCompensationAndResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |